Author: Lan, Jiaming; Yao, Yanfeng; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Bao, Linlin; Deng, Wei; Wei, Qiang; Gao, George F.; Qin, Chuan; Tan, Wenjie
Title: Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge() Document date: 2015_8_18
ID: q8i2gfut_21
Snippet: To evaluate the antigen-specific T-cell response induced by rRBD protein in immunised monkeys, an IFN-γ ELISpot assay was performed as described previously (Wen et al., 2013) . After PBMCs were isolated from EDTA-treated blood, IFN-γ ELISpot assay was carried out according to the manufacturer's instructions. Briefly, 2.5 × 10 5 cells per well were stimulated with pools of 15-mer peptides overlapping by 11 amino acids spanning the RBD protein o.....
Document: To evaluate the antigen-specific T-cell response induced by rRBD protein in immunised monkeys, an IFN-γ ELISpot assay was performed as described previously (Wen et al., 2013) . After PBMCs were isolated from EDTA-treated blood, IFN-γ ELISpot assay was carried out according to the manufacturer's instructions. Briefly, 2.5 × 10 5 cells per well were stimulated with pools of 15-mer peptides overlapping by 11 amino acids spanning the RBD protein of MERS-CoV at a final concentration of 4 μg/mL into a PVDF membrane-bottomed plate pre-coated with anti-monkey IFN-γ capture antibody. A set of negative control wells comprising media only were included on each plate. After stimulation for 20-24 h, IFN-γ-spot-forming cells were detected by staining membranes with the detection antibody (7-B6-1-biotin) followed by streptavidin-horseradish peroxidase and development with TMB (3, 3′, 5, 5′-tetramethylbenzidine) substrate solution. Results are presented as spot-forming cells per 10 6 PBMCs. Values were reported as the mean of the test wells minus the mean of all negative-control wells.
Search related documents:
Co phrase search for related documents- amino acid and detection antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- amino acid and elispot assay: 1, 2
- amino acid and final concentration: 1, 2, 3, 4, 5, 6
- amino acid and MERS CoV RBD protein: 1, 2, 3
- amino acid and negative control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- amino acid and previously describe: 1, 2, 3
- amino acid and RBD protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- amino acid and rrbd protein: 1
- amino acid and substrate solution: 1
- capture antibody and detection antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- capture antibody and elispot assay: 1, 2
- capture antibody and IFN γ elispot assay: 1
- capture antibody and negative control: 1, 2
- capture antibody and RBD protein: 1
- detection antibody and elispot assay: 1, 2
- detection antibody and final concentration: 1, 2
Co phrase search for related documents, hyperlinks ordered by date